Clin2
NCT05931458Possibly a fitNot yet recruiting

Appendix removal versus anti-TNF medicine for left UC

Ulcerative Colitis

Treatments studied

Part of Digestive system clinical trials.

This trial compares having your appendix removed versus taking an anti-TNF medicine to help control active left-sided ulcerative colitis. It’s for people whose symptoms haven’t improved with usual treatments and who may be able to use anti-TNF therapy.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
94 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are at least 18 years old.
  • Your ulcerative colitis affects the left side of the colon (up to the middle transverse colon).
  • You have active symptoms that did not respond to standard treatments.
  • Your doctor says you are a candidate for anti-TNF medicine.
  • You are willing to consent to an appendix-removal surgery if assigned.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT05733845Recruiting
Study of why some bowel inflammation treatments don’t work

This study looks at blood and/or tissue “molecular” (cell-level) reasons why treatments don’t fully work in adults with Crohn’s disease or ulcerative colitis. If you are starting a biologic or small-molecule medicine and still have moderate to severe symptoms, you may be able to contribute to research that helps improve future care.

Vandœuvre-lès-Nancy, CHRU de Nancy
NCT04183608Recruiting· Phase 4
Telemonitoring and education to guide treatment for ulcerative colitis

This trial tests whether “treat-to-target” care—guided by regular symptom checks, telemonitoring, and patient education—works better than standard follow-up when starting adalimumab for ulcerative colitis. It aims to help control inflammation more effectively and reduce flare-ups.

Cholet, Maine Et Loire
NCT04646187Enrolling by invitation· Phase 4
Lowering biologic doses for Crohn’s and ulcerative colitis

This trial tests whether people with Crohn’s disease or ulcerative colitis who are currently well-controlled can safely use less-frequent anti-TNF medicine. It may help reduce treatment intensity while keeping inflammation under control.

Ghent
NCT03681652Recruiting
Study of recovery outcomes after Crohn’s surgery in children

This study looks at outcomes after children with Crohn’s disease have part of the bowel removed (ileo-cecal resection). It may help doctors improve post-surgery care, especially for preventing flare-ups in the months after surgery.

Petah Tikva, Israel
NCT07347834Recruiting
Should you continue meds or have colitis surgery?

This trial studies whether continuing advanced medical treatments or having surgery (colectomy) is better for people with ulcerative colitis whose disease is active and hasn't improved after trying two or more advanced therapies.

Solna, Stockholm County
NCT07587450Not yet recruiting· Phase 3
Antibiotics vs. Surgery for Childhood Appendicitis

This study tests whether children with early appendicitis (inflammation of the appendix) can be treated safely with antibiotics instead of surgery. Researchers want to see if antibiotics work as well as surgery while avoiding the risks of an operation.

Bordeaux

Hear when a new Ulcerative Colitis trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.